Boeing Valuation
Is 0BOE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0BOE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0BOE ($145.06) is trading below our estimate of fair value ($300.52)
Significantly Below Fair Value: 0BOE is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0BOE?
Key metric: As 0BOE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0BOE's PS Ratio? | |
|---|---|
| PS Ratio | 1.5x |
| Sales | US$73.29b |
| Market Cap | US$108.79b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.1x |
| Enterprise Value/EBITDA | -39.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0BOE's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.6x | ||
BA. BAE Systems | 1.6x | 8.7% | UK£39.3b |
RR. Rolls-Royce Holdings | 2.5x | 5.5% | UK£44.6b |
MRO Melrose Industries | 1.9x | 6.9% | UK£6.6b |
BAB Babcock International Group | 0.6x | 3.7% | UK£2.6b |
0BOE Boeing | 1.5x | 13.3% | US$108.8b |
Price-To-Sales vs Peers: 0BOE is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (1.6x).
Price to Sales Ratio vs Industry
How does 0BOE's PS Ratio compare vs other companies in the European Aerospace & Defense Industry?
| 3 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: 0BOE is good value based on its Price-To-Sales Ratio (1.5x) compared to the European Aerospace & Defense industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is 0BOE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.5x |
| Fair PS Ratio | 1.2x |
Price-To-Sales vs Fair Ratio: 0BOE is expensive based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$145.06 | US$182.42 +25.8% | 17.2% | US$250.00 | US$85.00 | n/a | 24 |
| Nov ’25 | US$154.46 | US$182.63 +18.2% | 17.1% | US$250.00 | US$86.00 | n/a | 24 |
| Oct ’25 | US$154.20 | US$209.96 +36.2% | 14.8% | US$275.00 | US$110.00 | n/a | 24 |
| Sep ’25 | US$171.80 | US$220.28 +28.2% | 10.8% | US$275.00 | US$185.00 | n/a | 25 |
| Aug ’25 | US$178.40 | US$220.76 +23.7% | 11.2% | US$275.00 | US$175.00 | n/a | 25 |
| Jul ’25 | US$186.52 | US$218.08 +16.9% | 11.8% | US$275.00 | US$175.00 | n/a | 25 |
| Jun ’25 | US$176.21 | US$224.51 +27.4% | 13.9% | US$300.00 | US$175.00 | n/a | 27 |
| May ’25 | US$170.85 | US$225.83 +32.2% | 16.1% | US$300.00 | US$140.00 | n/a | 28 |
| Apr ’25 | US$193.24 | US$243.73 +26.1% | 10.5% | US$300.00 | US$200.00 | n/a | 28 |
| Mar ’25 | US$201.59 | US$258.33 +28.1% | 9.7% | US$300.00 | US$200.00 | n/a | 28 |
| Feb ’25 | US$209.82 | US$258.10 +23.0% | 10.7% | US$315.00 | US$190.00 | n/a | 29 |
| Jan ’25 | US$260.82 | US$267.86 +2.7% | 12.2% | US$320.00 | US$190.00 | n/a | 29 |
| Dec ’24 | US$235.03 | US$248.03 +5.5% | 9.6% | US$300.00 | US$190.00 | n/a | 29 |
| Nov ’24 | US$189.31 | US$240.33 +27.0% | 9.9% | US$275.00 | US$190.00 | US$154.46 | 27 |
| Oct ’24 | US$190.52 | US$254.17 +33.4% | 10.8% | US$310.00 | US$204.00 | US$154.20 | 23 |
| Sep ’24 | US$223.22 | US$256.45 +14.9% | 10.1% | US$310.00 | US$210.00 | US$171.80 | 22 |
| Aug ’24 | US$240.00 | US$253.66 +5.7% | 10.6% | US$310.00 | US$210.00 | US$178.40 | 21 |
| Jul ’24 | US$212.26 | US$233.29 +9.9% | 9.8% | US$291.00 | US$180.00 | US$186.52 | 24 |
| Jun ’24 | US$210.00 | US$235.45 +12.1% | 9.3% | US$291.00 | US$180.00 | US$176.21 | 22 |
| May ’24 | US$204.50 | US$232.96 +13.9% | 11.5% | US$291.00 | US$163.10 | US$170.85 | 21 |
| Apr ’24 | US$212.93 | US$228.26 +7.2% | 10.2% | US$261.00 | US$163.10 | US$193.24 | 20 |
| Mar ’24 | US$202.07 | US$227.86 +12.8% | 10.2% | US$261.00 | US$163.10 | US$201.59 | 21 |
| Feb ’24 | US$214.63 | US$225.41 +5.0% | 12.3% | US$261.00 | US$160.00 | US$209.82 | 20 |
| Jan ’24 | US$187.84 | US$203.91 +8.6% | 14.3% | US$250.00 | US$121.00 | US$260.82 | 20 |
| Dec ’23 | US$176.64 | US$192.26 +8.8% | 15.7% | US$250.00 | US$121.00 | US$235.03 | 20 |
| Nov ’23 | US$144.30 | US$189.24 +31.1% | 17.3% | US$250.00 | US$98.00 | US$189.31 | 21 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Aalberts
€3.8b
Offers mission-critical technologies for aerospace, automotive, building, and maritime sectors.
0NX1
€34.71
7D
0.7%
1Y
-3.0%
Renold
UK£106.4m
Engages in the manufacture and sale of high precision engineered products and solutions in the United Kingdom, rest of Europe, the United States, Canada, Australasia, China, India, and internationally.
RNO
UK£0.54
7D
-1.8%
1Y
59.6%
Per Aarsleff Holding
DKK 7.4b
Engages in the construction and maintenance of infrastructure and building structures of society in Denmark and internationally.
0REQ
DKK 410.50
7D
-1.8%
1Y
27.0%